Table 3.
Relationship between adipose tissue (AT) distribution and disease characteristics (FIGO stage, histology, and other histopathological features).
| Relationship between AT distribution and higher FIGO stage | Patiënts (n) | SATI/SAV | VATI/VAV | TAV | VAV% | HRSMI | BMI | |
|---|---|---|---|---|---|---|---|---|
| de Paula | 545 | p = 0.034 | p = 0.085 | x | x | p = 0.044 | x | |
| Mauland | 227 | p = 0.66 | p = 0.79 | p = 0.90 | p = 0.21 | x | x | |
| Donkers | 176 | p = 0.17 | p = 0.45 | p = 0.17 | p = 0.88 | x | p = 0.036 | |
| Relationship between AT distribution and histology (Type I and II endometrial cancer) | Patiënts (n) | VFA/VAV | SFA/SAV | TFA/TAV | VAV% | BMI | ||
| Nakamura* | 122 | p = 0.309 | p = 0.005 | p = 0.006 | x | p = 0.006 | ||
| Donkers | 176 | p = 0.64 | p = 0.28 | p = 0.88 | p = 0.97 | p = 0.66 | ||
| Relationship between AT distribution (VAT%) and histopathological features ** | Patients (n) | Histology | Grade | Myometrial invasion depth | Tumor size | Positive lymph node status | LVSI | |
| Ye | 122 | p = 0.381 | p = 0.069 | p = 0.093 | p = 0.791 | p = 0.042 | p = 0.582 | |
SATI, subcutaneous adipose tissue index; SAV, subcutaneous abdominal fat volume; SFA, subcutaneous fat area; VATI, visceral adipose tissue index; VAV, visceral abdominal fat volume; VFA, visceral fat area; TAV, total abdominal fat volume; TFA, total fat area; VAV%, percentage of visceral fat volume; HRSMI, high-radiodensity skeletal muscle index; BMI, body mass index; LVSI, lympho-vascular invasion; x, outcome not included in article. *, significant in type II EC; **, (VAT % < 31.89% and VAT% ≥ 31.89%).
Bold values are statistical significant values.